Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 5.53985059 |
2 | central nervous system myelination (GO:0022010) | 5.53985059 |
3 | synaptic vesicle maturation (GO:0016188) | 5.47035575 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.22524602 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.93319865 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.83936814 |
7 | glutamate secretion (GO:0014047) | 4.60781553 |
8 | neuronal action potential propagation (GO:0019227) | 4.56537108 |
9 | L-amino acid import (GO:0043092) | 4.47603572 |
10 | locomotory exploration behavior (GO:0035641) | 4.47245358 |
11 | synaptic vesicle exocytosis (GO:0016079) | 4.44258915 |
12 | cerebellar granule cell differentiation (GO:0021707) | 4.38032113 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.33293404 |
14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.26412350 |
15 | postsynaptic membrane organization (GO:0001941) | 4.21786141 |
16 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13774435 |
17 | vocalization behavior (GO:0071625) | 4.06496584 |
18 | protein localization to synapse (GO:0035418) | 4.05788835 |
19 | positive regulation of synapse maturation (GO:0090129) | 4.03397531 |
20 | neuron cell-cell adhesion (GO:0007158) | 4.01015936 |
21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.92219777 |
22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.91939635 |
23 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91166910 |
24 | regulation of synaptic vesicle transport (GO:1902803) | 3.86826953 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 3.83944269 |
26 | cellular potassium ion homeostasis (GO:0030007) | 3.81048601 |
27 | glycine transport (GO:0015816) | 3.80702830 |
28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.73037981 |
29 | neuron-neuron synaptic transmission (GO:0007270) | 3.69705902 |
30 | glutamate receptor signaling pathway (GO:0007215) | 3.69044649 |
31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.66477684 |
32 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.64708642 |
33 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.61274940 |
34 | positive regulation of dendritic spine development (GO:0060999) | 3.56336036 |
35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54425564 |
36 | proline transport (GO:0015824) | 3.51966443 |
37 | dendritic spine morphogenesis (GO:0060997) | 3.50106411 |
38 | neurotransmitter secretion (GO:0007269) | 3.49617988 |
39 | cellular sodium ion homeostasis (GO:0006883) | 3.47419985 |
40 | cell communication by electrical coupling (GO:0010644) | 3.47366786 |
41 | transmission of nerve impulse (GO:0019226) | 3.46975453 |
42 | neuron recognition (GO:0008038) | 3.45395124 |
43 | gamma-aminobutyric acid transport (GO:0015812) | 3.44700436 |
44 | neurotransmitter uptake (GO:0001504) | 3.43315752 |
45 | long-term memory (GO:0007616) | 3.42108481 |
46 | adult walking behavior (GO:0007628) | 3.41314964 |
47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39970804 |
48 | exploration behavior (GO:0035640) | 3.37755049 |
49 | serotonin metabolic process (GO:0042428) | 3.37035011 |
50 | positive regulation of membrane potential (GO:0045838) | 3.35230073 |
51 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.34575874 |
52 | presynaptic membrane organization (GO:0097090) | 3.32485914 |
53 | amino acid import (GO:0043090) | 3.32301094 |
54 | neuromuscular synaptic transmission (GO:0007274) | 3.30549677 |
55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.29606051 |
56 | sodium ion export (GO:0071436) | 3.28596844 |
57 | phosphorelay signal transduction system (GO:0000160) | 3.28260785 |
58 | acidic amino acid transport (GO:0015800) | 3.26309026 |
59 | neurotransmitter transport (GO:0006836) | 3.25733411 |
60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.25284322 |
61 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.23272874 |
62 | neuronal ion channel clustering (GO:0045161) | 3.21684300 |
63 | presynaptic membrane assembly (GO:0097105) | 3.21398857 |
64 | regulation of synapse maturation (GO:0090128) | 3.21282015 |
65 | regulation of dendritic spine development (GO:0060998) | 3.21041947 |
66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20050969 |
67 | synaptic transmission (GO:0007268) | 3.19797023 |
68 | rhodopsin mediated signaling pathway (GO:0016056) | 3.17855343 |
69 | myelination (GO:0042552) | 3.17290964 |
70 | regulation of synaptic plasticity (GO:0048167) | 3.17046783 |
71 | neuromuscular process controlling posture (GO:0050884) | 3.16847822 |
72 | layer formation in cerebral cortex (GO:0021819) | 3.15840255 |
73 | axon ensheathment (GO:0008366) | 3.15059931 |
74 | ensheathment of neurons (GO:0007272) | 3.15059931 |
75 | detection of calcium ion (GO:0005513) | 3.14502399 |
76 | regulation of ARF protein signal transduction (GO:0032012) | 3.14283983 |
77 | potassium ion import (GO:0010107) | 3.14261684 |
78 | cell differentiation in hindbrain (GO:0021533) | 3.13624952 |
79 | chemosensory behavior (GO:0007635) | 3.13204170 |
80 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.12545891 |
81 | regulation of synaptic transmission (GO:0050804) | 3.12170989 |
82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11829755 |
83 | membrane hyperpolarization (GO:0060081) | 3.10764850 |
84 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.10301531 |
85 | negative regulation of neurotransmitter transport (GO:0051589) | 3.07483446 |
86 | axonal fasciculation (GO:0007413) | 3.07073472 |
87 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06442078 |
88 | regulation of synapse structural plasticity (GO:0051823) | 3.03960571 |
89 | regulation of neurotransmitter secretion (GO:0046928) | 3.02666806 |
90 | primary amino compound metabolic process (GO:1901160) | 3.01867422 |
91 | long-term synaptic potentiation (GO:0060291) | 3.01554250 |
92 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.00822898 |
93 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.00011165 |
94 | neuromuscular process controlling balance (GO:0050885) | 2.99922321 |
95 | synaptic vesicle endocytosis (GO:0048488) | 2.99453748 |
96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98584906 |
97 | potassium ion homeostasis (GO:0055075) | 2.96786529 |
98 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94457903 |
99 | cell communication involved in cardiac conduction (GO:0086065) | 2.94275061 |
100 | establishment of synaptic vesicle localization (GO:0097480) | 2.92810337 |
101 | synaptic vesicle transport (GO:0048489) | 2.92810337 |
102 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92335289 |
103 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.92018411 |
104 | regulation of vesicle fusion (GO:0031338) | 2.90399430 |
105 | vesicle transport along microtubule (GO:0047496) | 2.89757970 |
106 | startle response (GO:0001964) | 2.89398380 |
107 | dendrite morphogenesis (GO:0048813) | 2.89287029 |
108 | establishment of mitochondrion localization (GO:0051654) | 2.88180614 |
109 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.86324476 |
110 | membrane depolarization (GO:0051899) | 2.86079271 |
111 | membrane depolarization during action potential (GO:0086010) | 2.85104738 |
112 | regulation of neurotransmitter levels (GO:0001505) | 2.84499870 |
113 | regulation of neurotransmitter transport (GO:0051588) | 2.83690644 |
114 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.81311661 |
115 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79075641 |
116 | eye photoreceptor cell differentiation (GO:0001754) | 2.78682421 |
117 | photoreceptor cell differentiation (GO:0046530) | 2.78682421 |
118 | nerve growth factor signaling pathway (GO:0038180) | 2.78432027 |
119 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.78017781 |
120 | organelle transport along microtubule (GO:0072384) | 2.77329756 |
121 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.77027968 |
122 | dendritic spine organization (GO:0097061) | 2.75684529 |
123 | innervation (GO:0060384) | 2.75158508 |
124 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.73536526 |
125 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.72676686 |
126 | neuromuscular process (GO:0050905) | 2.71825635 |
127 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.71355668 |
128 | auditory behavior (GO:0031223) | 2.70536127 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.09007989 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61812201 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87848249 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82089816 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73508953 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50366983 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50366983 |
8 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42636590 |
9 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42507079 |
10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42080375 |
11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.37043296 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36467040 |
13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35979827 |
14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33535167 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29957950 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23930768 |
17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22811239 |
18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14921841 |
19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11993397 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06582877 |
21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00945248 |
22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.91750084 |
23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91220045 |
24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79998273 |
25 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.70267426 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68300910 |
27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62531262 |
28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61673286 |
29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61047803 |
30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56986087 |
31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56488130 |
32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55488098 |
33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50785118 |
34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49166020 |
35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45787753 |
36 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44810939 |
37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44665964 |
38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41973160 |
39 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40652662 |
40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39016825 |
41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36882936 |
42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.32659244 |
43 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.32260642 |
44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31384683 |
45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30162687 |
46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29947277 |
47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29111002 |
48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25626215 |
49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24328917 |
50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23479102 |
51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21832258 |
52 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21601880 |
53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20819369 |
54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20514337 |
55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20323794 |
56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19881736 |
57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18813247 |
58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16673563 |
59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16326020 |
60 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14827597 |
61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13919477 |
62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12519401 |
63 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11684336 |
64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10661663 |
65 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09790645 |
66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09665429 |
67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09630306 |
68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09630306 |
69 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09195989 |
70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09117077 |
71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08899956 |
72 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08459435 |
73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08263624 |
74 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07953429 |
75 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07436906 |
76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07250575 |
77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05440645 |
78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05377628 |
79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04890816 |
80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04579211 |
81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04279916 |
82 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04195307 |
83 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04130103 |
84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03294208 |
85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00505313 |
86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00320405 |
87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00278602 |
88 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00083505 |
89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99918104 |
90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99058261 |
91 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97294345 |
92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96660137 |
93 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.95964312 |
94 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95901344 |
95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94259156 |
96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94207242 |
97 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93334371 |
98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93181700 |
99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93155579 |
100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92339787 |
101 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92157367 |
102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92120578 |
103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91783078 |
104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91775110 |
105 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91528908 |
106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91511634 |
107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91044317 |
108 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90183571 |
109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89688030 |
110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88815113 |
111 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87032497 |
112 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86577816 |
113 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86509266 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.84238145 |
2 | MP0003880_abnormal_central_pattern | 5.13354971 |
3 | MP0004270_analgesia | 3.92064976 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.67839128 |
5 | MP0002064_seizures | 3.11085487 |
6 | MP0009745_abnormal_behavioral_response | 3.05065692 |
7 | MP0005423_abnormal_somatic_nervous | 3.04261375 |
8 | MP0002272_abnormal_nervous_system | 2.94877495 |
9 | MP0002063_abnormal_learning/memory/cond | 2.87091523 |
10 | MP0001486_abnormal_startle_reflex | 2.84573870 |
11 | MP0005551_abnormal_eye_electrophysiolog | 2.68459071 |
12 | MP0009046_muscle_twitch | 2.68266926 |
13 | MP0001968_abnormal_touch/_nociception | 2.47848964 |
14 | MP0002572_abnormal_emotion/affect_behav | 2.45985099 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.41579414 |
16 | MP0000920_abnormal_myelination | 2.39298022 |
17 | MP0002822_catalepsy | 2.22929588 |
18 | MP0003329_amyloid_beta_deposits | 2.10107077 |
19 | MP0004885_abnormal_endolymph | 2.09992733 |
20 | MP0001501_abnormal_sleep_pattern | 1.97405856 |
21 | MP0008569_lethality_at_weaning | 1.89529145 |
22 | MP0002735_abnormal_chemical_nociception | 1.86913795 |
23 | MP0002067_abnormal_sensory_capabilities | 1.83502862 |
24 | MP0002229_neurodegeneration | 1.83006136 |
25 | MP0001440_abnormal_grooming_behavior | 1.81667940 |
26 | MP0002736_abnormal_nociception_after | 1.81237279 |
27 | MP0001970_abnormal_pain_threshold | 1.80775036 |
28 | MP0000778_abnormal_nervous_system | 1.79800154 |
29 | MP0002733_abnormal_thermal_nociception | 1.68565638 |
30 | MP0002882_abnormal_neuron_morphology | 1.67272804 |
31 | MP0005253_abnormal_eye_physiology | 1.67016165 |
32 | MP0003690_abnormal_glial_cell | 1.63545530 |
33 | MP0000955_abnormal_spinal_cord | 1.63239018 |
34 | MP0004142_abnormal_muscle_tone | 1.61386259 |
35 | MP0009780_abnormal_chondrocyte_physiolo | 1.55796332 |
36 | MP0003633_abnormal_nervous_system | 1.55361202 |
37 | MP0006072_abnormal_retinal_apoptosis | 1.54513785 |
38 | MP0004811_abnormal_neuron_physiology | 1.53420015 |
39 | MP0005386_behavior/neurological_phenoty | 1.51038621 |
40 | MP0004924_abnormal_behavior | 1.51038621 |
41 | MP0004742_abnormal_vestibular_system | 1.50465699 |
42 | MP0003634_abnormal_glial_cell | 1.50397915 |
43 | MP0001529_abnormal_vocalization | 1.47946462 |
44 | MP0002184_abnormal_innervation | 1.46902425 |
45 | MP0001984_abnormal_olfaction | 1.44806758 |
46 | MP0002066_abnormal_motor_capabilities/c | 1.43316723 |
47 | MP0002557_abnormal_social/conspecific_i | 1.41958196 |
48 | MP0005646_abnormal_pituitary_gland | 1.41612379 |
49 | MP0001905_abnormal_dopamine_level | 1.40718724 |
50 | MP0003631_nervous_system_phenotype | 1.36779988 |
51 | MP0001502_abnormal_circadian_rhythm | 1.34236329 |
52 | MP0005409_darkened_coat_color | 1.31366404 |
53 | MP0003123_paternal_imprinting | 1.29585254 |
54 | MP0002909_abnormal_adrenal_gland | 1.29023752 |
55 | MP0003011_delayed_dark_adaptation | 1.24536650 |
56 | MP0001485_abnormal_pinna_reflex | 1.24437115 |
57 | MP0005171_absent_coat_pigmentation | 1.20724892 |
58 | MP0002752_abnormal_somatic_nervous | 1.20325044 |
59 | MP0004043_abnormal_pH_regulation | 1.19541064 |
60 | MP0005410_abnormal_fertilization | 1.18176796 |
61 | MP0004858_abnormal_nervous_system | 1.18167495 |
62 | MP0000569_abnormal_digit_pigmentation | 1.17733152 |
63 | MP0004147_increased_porphyrin_level | 1.13916245 |
64 | MP0005645_abnormal_hypothalamus_physiol | 1.13597459 |
65 | MP0003879_abnormal_hair_cell | 1.11731701 |
66 | MP0003632_abnormal_nervous_system | 1.11684274 |
67 | MP0003950_abnormal_plasma_membrane | 1.10367343 |
68 | MP0003122_maternal_imprinting | 1.08078271 |
69 | MP0005195_abnormal_posterior_eye | 1.08000185 |
70 | MP0006276_abnormal_autonomic_nervous | 1.07348127 |
71 | MP0004145_abnormal_muscle_electrophysio | 1.06917513 |
72 | MP0001963_abnormal_hearing_physiology | 1.06533227 |
73 | MP0002090_abnormal_vision | 1.06048050 |
74 | MP0002152_abnormal_brain_morphology | 1.02503590 |
75 | MP0008877_abnormal_DNA_methylation | 0.95535228 |
76 | MP0001177_atelectasis | 0.93245887 |
77 | MP0003787_abnormal_imprinting | 0.90998513 |
78 | MP0000604_amyloidosis | 0.88696942 |
79 | MP0001188_hyperpigmentation | 0.85960575 |
80 | MP0000013_abnormal_adipose_tissue | 0.82350060 |
81 | MP0003075_altered_response_to | 0.78996035 |
82 | MP0002069_abnormal_eating/drinking_beha | 0.78189953 |
83 | MP0001346_abnormal_lacrimal_gland | 0.77237630 |
84 | MP0001299_abnormal_eye_distance/ | 0.76979092 |
85 | MP0001348_abnormal_lacrimal_gland | 0.76558063 |
86 | MP0000747_muscle_weakness | 0.75118424 |
87 | MP0002638_abnormal_pupillary_reflex | 0.74904106 |
88 | MP0005623_abnormal_meninges_morphology | 0.74690344 |
89 | MP0004085_abnormal_heartbeat | 0.74393530 |
90 | MP0008874_decreased_physiological_sensi | 0.73227872 |
91 | MP0000631_abnormal_neuroendocrine_gland | 0.67857930 |
92 | MP0000751_myopathy | 0.67843408 |
93 | MP0008872_abnormal_physiological_respon | 0.66964048 |
94 | MP0005394_taste/olfaction_phenotype | 0.66952135 |
95 | MP0005499_abnormal_olfactory_system | 0.66952135 |
96 | MP0004130_abnormal_muscle_cell | 0.65549493 |
97 | MP0005535_abnormal_body_temperature | 0.64244804 |
98 | MP0003283_abnormal_digestive_organ | 0.62744246 |
99 | MP0003137_abnormal_impulse_conducting | 0.61903604 |
100 | MP0003136_yellow_coat_color | 0.61226274 |
101 | MP0003045_fibrosis | 0.60517285 |
102 | MP0010769_abnormal_survival | 0.60293921 |
103 | MP0001664_abnormal_digestion | 0.59641690 |
104 | MP0003121_genomic_imprinting | 0.58483213 |
105 | MP0005391_vision/eye_phenotype | 0.58421430 |
106 | MP0010386_abnormal_urinary_bladder | 0.58258133 |
107 | MP0010770_preweaning_lethality | 0.57801376 |
108 | MP0002082_postnatal_lethality | 0.57801376 |
109 | MP0010768_mortality/aging | 0.57001234 |
110 | MP0001324_abnormal_eye_pigmentation | 0.56868201 |
111 | MP0001986_abnormal_taste_sensitivity | 0.56073463 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.56035941 |
113 | MP0000026_abnormal_inner_ear | 0.54266978 |
114 | MP0003861_abnormal_nervous_system | 0.53326297 |
115 | MP0000566_synostosis | 0.51189071 |
116 | MP0001943_abnormal_respiration | 0.50321898 |
117 | MP0003956_abnormal_body_size | 0.49964098 |
118 | MP0000579_abnormal_nail_morphology | 0.49175160 |
119 | MP0004215_abnormal_myocardial_fiber | 0.46678868 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.11148681 |
2 | Myokymia (HP:0002411) | 6.10314851 |
3 | Focal seizures (HP:0007359) | 4.49949437 |
4 | Supranuclear gaze palsy (HP:0000605) | 4.27856261 |
5 | Neurofibrillary tangles (HP:0002185) | 3.97341398 |
6 | Epileptic encephalopathy (HP:0200134) | 3.89895987 |
7 | Congenital stationary night blindness (HP:0007642) | 3.86650924 |
8 | Action tremor (HP:0002345) | 3.78995571 |
9 | Ankle clonus (HP:0011448) | 3.75843709 |
10 | Visual hallucinations (HP:0002367) | 3.64447208 |
11 | Atonic seizures (HP:0010819) | 3.60527431 |
12 | Dysmetria (HP:0001310) | 3.54868833 |
13 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.53510008 |
14 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.53510008 |
15 | Progressive cerebellar ataxia (HP:0002073) | 3.52579266 |
16 | Central scotoma (HP:0000603) | 3.46495894 |
17 | Febrile seizures (HP:0002373) | 3.40394706 |
18 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.40263840 |
19 | Peripheral hypomyelination (HP:0007182) | 3.26391823 |
20 | Spastic gait (HP:0002064) | 3.23393043 |
21 | Abnormality of the corticospinal tract (HP:0002492) | 3.22596096 |
22 | Cerebral inclusion bodies (HP:0100314) | 3.21747148 |
23 | Abnormality of macular pigmentation (HP:0008002) | 3.17555873 |
24 | Hemiplegia (HP:0002301) | 3.13949836 |
25 | Status epilepticus (HP:0002133) | 3.10120752 |
26 | Intention tremor (HP:0002080) | 3.09354517 |
27 | Absence seizures (HP:0002121) | 3.03114182 |
28 | Generalized tonic-clonic seizures (HP:0002069) | 3.02372731 |
29 | Dialeptic seizures (HP:0011146) | 3.00078370 |
30 | Insidious onset (HP:0003587) | 2.95472102 |
31 | Termporal pattern (HP:0011008) | 2.95472102 |
32 | Dysdiadochokinesis (HP:0002075) | 2.94567854 |
33 | Scanning speech (HP:0002168) | 2.92983402 |
34 | Postural instability (HP:0002172) | 2.91734180 |
35 | Gaze-evoked nystagmus (HP:0000640) | 2.91394419 |
36 | Onion bulb formation (HP:0003383) | 2.87939610 |
37 | Broad-based gait (HP:0002136) | 2.87322814 |
38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.85055078 |
39 | Truncal ataxia (HP:0002078) | 2.84066895 |
40 | Scotoma (HP:0000575) | 2.74417001 |
41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.72104087 |
42 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.71585783 |
43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.69727170 |
44 | Hypsarrhythmia (HP:0002521) | 2.65636330 |
45 | Depression (HP:0000716) | 2.64922674 |
46 | Obstructive sleep apnea (HP:0002870) | 2.63085771 |
47 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.61858837 |
48 | Urinary urgency (HP:0000012) | 2.59175878 |
49 | Choroideremia (HP:0001139) | 2.55931936 |
50 | Hyperventilation (HP:0002883) | 2.55398047 |
51 | Dyschromatopsia (HP:0007641) | 2.55346861 |
52 | Anxiety (HP:0000739) | 2.54637198 |
53 | Akinesia (HP:0002304) | 2.53866842 |
54 | Poor eye contact (HP:0000817) | 2.50395334 |
55 | Megalencephaly (HP:0001355) | 2.49609509 |
56 | Lower limb muscle weakness (HP:0007340) | 2.45754464 |
57 | Abolished electroretinogram (ERG) (HP:0000550) | 2.45726811 |
58 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.45629551 |
59 | Decreased central vision (HP:0007663) | 2.45042008 |
60 | Retinal dysplasia (HP:0007973) | 2.43849672 |
61 | Pheochromocytoma (HP:0002666) | 2.40524711 |
62 | Tetraplegia (HP:0002445) | 2.38637196 |
63 | Annular pancreas (HP:0001734) | 2.37462851 |
64 | Impaired vibratory sensation (HP:0002495) | 2.31356073 |
65 | Impaired social interactions (HP:0000735) | 2.27591487 |
66 | Abnormal social behavior (HP:0012433) | 2.27591487 |
67 | Cerebral hypomyelination (HP:0006808) | 2.27431175 |
68 | Hemiparesis (HP:0001269) | 2.26406393 |
69 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.24132518 |
70 | Mutism (HP:0002300) | 2.22478158 |
71 | Increased circulating renin level (HP:0000848) | 2.22473701 |
72 | Torticollis (HP:0000473) | 2.21532393 |
73 | Sleep apnea (HP:0010535) | 2.17245764 |
74 | Excessive salivation (HP:0003781) | 2.17039350 |
75 | Drooling (HP:0002307) | 2.17039350 |
76 | Abnormal eating behavior (HP:0100738) | 2.14773499 |
77 | Clonus (HP:0002169) | 2.14607140 |
78 | Delusions (HP:0000746) | 2.14589122 |
79 | Choreoathetosis (HP:0001266) | 2.14154843 |
80 | Craniofacial dystonia (HP:0012179) | 2.13502236 |
81 | Amblyopia (HP:0000646) | 2.13455574 |
82 | Attenuation of retinal blood vessels (HP:0007843) | 2.12981893 |
83 | Bundle branch block (HP:0011710) | 2.12925213 |
84 | Absent speech (HP:0001344) | 2.11292595 |
85 | Slow saccadic eye movements (HP:0000514) | 2.10411487 |
86 | Genetic anticipation (HP:0003743) | 2.07151301 |
87 | Blue irides (HP:0000635) | 2.06426090 |
88 | Clumsiness (HP:0002312) | 2.05661112 |
89 | Limb dystonia (HP:0002451) | 2.04900656 |
90 | Progressive inability to walk (HP:0002505) | 2.03989668 |
91 | Bradykinesia (HP:0002067) | 2.02893682 |
92 | Papilledema (HP:0001085) | 2.02488286 |
93 | Abnormal auditory evoked potentials (HP:0006958) | 2.02486643 |
94 | CNS hypomyelination (HP:0003429) | 2.02080556 |
95 | Generalized myoclonic seizures (HP:0002123) | 2.00719758 |
96 | Alacrima (HP:0000522) | 2.00713304 |
97 | Neuroendocrine neoplasm (HP:0100634) | 2.00018484 |
98 | Thickened helices (HP:0000391) | 1.98989246 |
99 | Abnormality of binocular vision (HP:0011514) | 1.98729148 |
100 | Diplopia (HP:0000651) | 1.98729148 |
101 | Split foot (HP:0001839) | 1.96670057 |
102 | Focal dystonia (HP:0004373) | 1.96521514 |
103 | Spastic tetraparesis (HP:0001285) | 1.95715608 |
104 | Aplasia involving bones of the extremities (HP:0009825) | 1.94791777 |
105 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.94791777 |
106 | Aplasia of the phalanges of the hand (HP:0009802) | 1.94791777 |
107 | Type II lissencephaly (HP:0007260) | 1.94400267 |
108 | Absent/shortened dynein arms (HP:0200106) | 1.93527119 |
109 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.93527119 |
110 | Rigidity (HP:0002063) | 1.92311738 |
111 | Rapidly progressive (HP:0003678) | 1.92114713 |
112 | Incomplete penetrance (HP:0003829) | 1.91489571 |
113 | Abnormality of saccadic eye movements (HP:0000570) | 1.90595033 |
114 | Epileptiform EEG discharges (HP:0011182) | 1.90418468 |
115 | Impaired smooth pursuit (HP:0007772) | 1.88535302 |
116 | Paraplegia (HP:0010550) | 1.87993979 |
117 | Spastic paraplegia (HP:0001258) | 1.87858995 |
118 | Stereotypic behavior (HP:0000733) | 1.87352304 |
119 | Dysmetric saccades (HP:0000641) | 1.87128646 |
120 | Insomnia (HP:0100785) | 1.86287242 |
121 | Neuronal loss in central nervous system (HP:0002529) | 1.85947888 |
122 | Fetal akinesia sequence (HP:0001989) | 1.85325250 |
123 | Hammertoe (HP:0001765) | 1.84613497 |
124 | Polyphagia (HP:0002591) | 1.84365041 |
125 | Apathy (HP:0000741) | 1.84004227 |
126 | Abnormality of the periventricular white matter (HP:0002518) | 1.82738925 |
127 | Decreased motor nerve conduction velocity (HP:0003431) | 1.82284833 |
128 | Abnormality of the lower motor neuron (HP:0002366) | 1.79211165 |
129 | Prolonged QT interval (HP:0001657) | 1.78625385 |
130 | Spastic tetraplegia (HP:0002510) | 1.76742897 |
131 | Inability to walk (HP:0002540) | 1.75974590 |
132 | Bronchomalacia (HP:0002780) | 1.74777539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 3.93639344 |
2 | NTRK3 | 3.86950722 |
3 | STK39 | 2.80525706 |
4 | PRKD3 | 2.71732220 |
5 | MAP3K9 | 2.63203410 |
6 | MAP3K4 | 2.33462492 |
7 | OXSR1 | 2.29535886 |
8 | PAK6 | 2.24898019 |
9 | NTRK1 | 2.16671840 |
10 | MARK1 | 2.07680131 |
11 | MINK1 | 1.99220261 |
12 | MAP2K7 | 1.83480768 |
13 | DAPK2 | 1.78924071 |
14 | KSR2 | 1.78845606 |
15 | CDK19 | 1.74691823 |
16 | LATS2 | 1.71090645 |
17 | TNIK | 1.68474348 |
18 | PNCK | 1.65360916 |
19 | UHMK1 | 1.64873832 |
20 | WNK1 | 1.62460605 |
21 | RIPK4 | 1.59598944 |
22 | NTRK2 | 1.56966683 |
23 | CDK5 | 1.55907861 |
24 | CAMK2B | 1.55768161 |
25 | SGK494 | 1.51583437 |
26 | SGK223 | 1.51583437 |
27 | CASK | 1.47242553 |
28 | PKN1 | 1.43603375 |
29 | PINK1 | 1.41801857 |
30 | CAMKK1 | 1.40254678 |
31 | MAP2K4 | 1.27639911 |
32 | PRPF4B | 1.26447737 |
33 | WNK4 | 1.26121826 |
34 | MAPKAPK5 | 1.25377701 |
35 | MAP3K2 | 1.22335088 |
36 | CAMK2D | 1.20159239 |
37 | NEK6 | 1.16571427 |
38 | TYRO3 | 1.16116584 |
39 | FGFR2 | 1.13896782 |
40 | GRK5 | 1.13187877 |
41 | CAMK2A | 1.13167721 |
42 | MAPK13 | 1.10833925 |
43 | FRK | 1.09538024 |
44 | STK38 | 1.09040590 |
45 | FES | 1.08332354 |
46 | ARAF | 1.05893547 |
47 | PLK2 | 1.04186483 |
48 | PRKCH | 1.03426525 |
49 | PHKG1 | 1.00854926 |
50 | PHKG2 | 1.00854926 |
51 | PRKCG | 0.99859465 |
52 | MARK2 | 0.99819927 |
53 | MAP3K13 | 0.97072252 |
54 | PAK3 | 0.96496444 |
55 | CAMK2G | 0.92091582 |
56 | BCR | 0.91826632 |
57 | GRK1 | 0.91148384 |
58 | SIK2 | 0.88175534 |
59 | STK11 | 0.87970970 |
60 | CSNK1G2 | 0.87451410 |
61 | CDK15 | 0.87211419 |
62 | CDK14 | 0.86997342 |
63 | PDPK1 | 0.85325037 |
64 | CDK18 | 0.85190516 |
65 | CAMK1 | 0.83254705 |
66 | ROCK2 | 0.81317299 |
67 | PTK2B | 0.81101466 |
68 | BMPR2 | 0.80989636 |
69 | CAMK4 | 0.80901734 |
70 | KSR1 | 0.79912723 |
71 | PDK1 | 0.79904042 |
72 | MAP3K12 | 0.76154643 |
73 | CDK11A | 0.75338292 |
74 | SGK1 | 0.72990338 |
75 | ALK | 0.72946068 |
76 | MAPK12 | 0.70405966 |
77 | DAPK1 | 0.68959699 |
78 | RET | 0.68268165 |
79 | EPHB1 | 0.68120737 |
80 | CAMKK2 | 0.66107199 |
81 | ICK | 0.64559968 |
82 | CAMK1G | 0.64360255 |
83 | PRKCE | 0.63552702 |
84 | CSNK1A1L | 0.63108949 |
85 | MAP3K1 | 0.62799541 |
86 | FGR | 0.62754529 |
87 | LIMK1 | 0.62528796 |
88 | DYRK1A | 0.62097972 |
89 | INSRR | 0.56621415 |
90 | MAP3K7 | 0.56424544 |
91 | FYN | 0.55949167 |
92 | CLK1 | 0.55726401 |
93 | PRKD1 | 0.55461559 |
94 | CSNK1G3 | 0.55360446 |
95 | MAPK10 | 0.54019717 |
96 | CDC42BPA | 0.51940152 |
97 | CCNB1 | 0.51639127 |
98 | SGK3 | 0.51345362 |
99 | TNK2 | 0.50213300 |
100 | SGK2 | 0.49945140 |
101 | BRAF | 0.49552813 |
102 | PRKCZ | 0.49137640 |
103 | RPS6KA3 | 0.48193457 |
104 | RIPK1 | 0.46764656 |
105 | PRKCQ | 0.46611279 |
106 | LMTK2 | 0.46259349 |
107 | HIPK2 | 0.44693303 |
108 | PRKG1 | 0.44513801 |
109 | AKT3 | 0.42440130 |
110 | IRAK2 | 0.41598172 |
111 | BRSK1 | 0.40885871 |
112 | CSNK1D | 0.39802776 |
113 | PRKCA | 0.38376625 |
114 | PRKCB | 0.37337107 |
115 | MAP3K11 | 0.36323846 |
116 | CSNK1E | 0.35557694 |
117 | DAPK3 | 0.35162673 |
118 | CSNK1A1 | 0.33915075 |
119 | GSK3B | 0.31824987 |
120 | PRKACA | 0.30460677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 3.72334416 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.06731455 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.84487613 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.68004869 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63788740 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62668889 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.58294147 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53891269 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.44965851 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.35532996 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.29695557 |
12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19907470 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 2.10125176 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.06332974 |
15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00147160 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.97870205 |
17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.86823632 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82689748 |
19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.66699164 |
20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64627313 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57824209 |
22 | Long-term depression_Homo sapiens_hsa04730 | 1.57170582 |
23 | Taste transduction_Homo sapiens_hsa04742 | 1.57000903 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52297880 |
25 | Renin secretion_Homo sapiens_hsa04924 | 1.49515198 |
26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.47152078 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41433365 |
28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39408743 |
29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38881119 |
30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27366064 |
31 | Axon guidance_Homo sapiens_hsa04360 | 1.25378962 |
32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24905829 |
33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17340694 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12981051 |
35 | Gap junction_Homo sapiens_hsa04540 | 1.12334289 |
36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11507514 |
37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08086263 |
38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05422138 |
39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03437684 |
40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01040950 |
41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00427891 |
42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95281865 |
43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95221872 |
44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93651301 |
45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91275789 |
46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91140120 |
47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89121978 |
48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89075228 |
49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86426138 |
50 | Melanogenesis_Homo sapiens_hsa04916 | 0.86143823 |
51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86027071 |
52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85764488 |
53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84903234 |
54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84264134 |
55 | Glioma_Homo sapiens_hsa05214 | 0.83117145 |
56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77364304 |
57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76243482 |
58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75765598 |
59 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70868456 |
60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70613487 |
61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70210863 |
62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68634702 |
63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67106264 |
64 | Endocytosis_Homo sapiens_hsa04144 | 0.66709100 |
65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65618557 |
66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62895416 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62513765 |
68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62034212 |
69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60371673 |
70 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57439318 |
71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55952531 |
72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55771769 |
73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54438101 |
74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53656141 |
75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52325454 |
76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51904100 |
77 | Bile secretion_Homo sapiens_hsa04976 | 0.49254035 |
78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49205272 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49137232 |
80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48671252 |
81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47088508 |
82 | Mineral absorption_Homo sapiens_hsa04978 | 0.46123202 |
83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45276143 |
84 | Alcoholism_Homo sapiens_hsa05034 | 0.44238728 |
85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44142586 |
86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43912459 |
87 | Tight junction_Homo sapiens_hsa04530 | 0.43110530 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42825910 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.40223071 |
90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38922122 |
91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38327804 |
92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37246042 |
93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35973115 |
94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33944070 |
95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33415740 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33134000 |
97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32819209 |
98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32608233 |
99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31915843 |
100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31869548 |
101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31583539 |
102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.30486079 |
103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28759559 |
104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28468422 |
105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27998354 |
106 | ABC transporters_Homo sapiens_hsa02010 | 0.27236492 |
107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26309000 |
108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.26123464 |
109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25063744 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24204764 |
111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24025709 |